Combined hemodialysis-hemoperfusion in the treatment of secondary hyperparathyroidism of uremic patients

Blood Purif. 1991;9(3):148-52. doi: 10.1159/000170011.

Abstract

Hyperparathyroidism and its related symptoms such as bone pain, soft-tissue calcifications and pruritus often get worse during dialysis treatment. We have treated 12 cases among 170 patients on regular dialysis by using coated charcoal (150 g/cartridge) in combination with standard hemodialysis. During a 6-month treatment period, without changing medical therapy and diet regime, the patients reported a marked relief from pruritus. Parathyroid hormone (PTH) levels changed from 552 +/- 86 to 364 +/- 62 pg/ml (p less than 0.001) compared to the pretreatment period, Plasma PO4(3-) changed in the same period from 6.9 +/- 1.8 to 4.6 +/- 1.5 mg/dl (p less than 0.005). The results obtained indicate a relationship between PTH, serum plasma PO4(3-) levels and pruritus. The mechanism which may be involved is that hemoperfusion removes PTH excess by absorption. Our treatment reducing PTH levels resulted in a marked relief from pruritus and other symptoms, suggesting that patients in this condition, before undergoing surgical parathyroidectomy, may be usefully treated with this therapeutic modality.

MeSH terms

  • Adult
  • Alkaline Phosphatase / blood
  • Calcitonin / blood
  • Calcium / blood
  • Female
  • Hemoperfusion*
  • Humans
  • Hyperparathyroidism, Secondary / etiology
  • Hyperparathyroidism, Secondary / therapy*
  • Male
  • Middle Aged
  • Osteocalcin / blood
  • Parathyroid Hormone / blood
  • Renal Dialysis*
  • Uremia / complications*

Substances

  • Parathyroid Hormone
  • Osteocalcin
  • Calcitonin
  • Alkaline Phosphatase
  • Calcium